Portfolio Explorer
Select a portfolio...
▾
AUM
$
Portfolio
Factor AnalysisPortfolio
vs. Biotech Universe
| Factor | Loading (Z-Score) | Percentile | Exposure ($M) |
|---|
| Factor | Loading (Beta) | Percentile | Exposure ($M) |
|---|
Risk Timeline
| Ticker | Weight | Drug | Indication | Catalyst | Phase | Expected Move | Earliest Quarter | Timing |
|---|
Variance Explained
i
Methodology
Each day's portfolio return is decomposed into contributions from three biotech factor dimensions:
Stage — return attributable to your portfolio's clinical stage mix (Preclinical, Phase 1/2, Phase 3, Commercial)
TA — return from therapeutic area exposure (Oncology, Neuro, etc.)
Modality — return from drug modality tilt (Small Molecule, Biologics, Genetic Medicine)
Idiosyncratic — stock-specific return not explained by factors
R² measures what percentage of your portfolio's daily volatility is explained by these factor exposures (60-day rolling window). Higher R² = more factor-driven; lower = more stock-picking driven.
The white line shows cumulative total return.
Each day's portfolio return is decomposed into contributions from three biotech factor dimensions:
Stage — return attributable to your portfolio's clinical stage mix (Preclinical, Phase 1/2, Phase 3, Commercial)
TA — return from therapeutic area exposure (Oncology, Neuro, etc.)
Modality — return from drug modality tilt (Small Molecule, Biologics, Genetic Medicine)
Idiosyncratic — stock-specific return not explained by factors
R² measures what percentage of your portfolio's daily volatility is explained by these factor exposures (60-day rolling window). Higher R² = more factor-driven; lower = more stock-picking driven.
The white line shows cumulative total return.
Performance
Loading portfolio data...
The requested portfolio is not available. Choose another from the menu above.
Add Columns
New Allocation
Time Machine
View your portfolio on a historical date
Or select a comparison period
13F Biotech Specialists — Leaderboard
Compare:
Computing fund returns
Returns computed by stitching each fund's quarterly 13F holdings: each quarter rebalanced to that filing's positions, marked daily to close. Acquired/delisted names carry forward last known price within their segment. Cells show "—" when the fund had no 13F filings before the year started. Click any row to load the fund as the active portfolio.
Portfolio Drilldown
Select a portfolio first.
Perf = total return from first to last close in the window (XBI used as benchmark for the vs-XBI column). Holders Analysis columns are from the latest 13F filing quarter — Composite Rank/Score and Rank Δ from
/api/13f/composite, holder counts (KM/SP/HCG) are funds in each tier currently holding the ticker.
Composition
Factor Analysis
vs. Biotech Universe
| Factor | Value | Loading (Z-Score) | Percentile | Exposure ($M) |
|---|
| Factor | Loading (Beta) | Percentile | Exposure ($M) |
|---|